Bringing nature back into medicine.

Evithé Biotechnology is a bio‑pharmaceutical company that develops novel, patented botanical and multi‑target pharmaceutical prescription drugs from ginger rhizomes.

Inflammaory disease are the number 1 cause of death and disability worldwide.

Evithé Biotechnology is inspired by nature and has a pipeline of botanical and pharmaceutical prescription drugs that can address a range of disease targets to get to the root of inflammatory disorders such as Rheumatoid arthritis, Alzheimer’s disease and sepsis.

Botanical drugs are prescription medines that are intended to cure, mitigate, treat or prevent diseases.

Consumer surveys identified that 78% of patients prefer a Botanical Drug over a synthetic chemical. Botanical drugs have a short pathway to market and are available on prescription in the US, Europe & Asia.

Watch an in-depth interview with Cynthia's journey in founding Evithé and her mission of commercially developing complex botanicals.

Contact us

At our current stage we welcome interest from investors, as well as those that have a desire to follow our developments.

You can also connect with Evithé through our digital channels in order to stay up to date.

Evithé, life is in our name.

Evithé [eɪ Viː teɪ]

An early European derivative of the Hebrew Evia, meaning 'source (or breath) of life'.

©2022 Evithé Biotechnology